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The Clinical SYNTAX score has an additive predictive value in high risk patients
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Background: The SYNTAX score (SS) has been used as an angiographic grading
tool to determine the complexity of coronary diseases, and was veriﬁed to predict
outcomes after revascularization. However, the SS neglected clinical factors, which
brought up an alternative, the clinical SS (cSS). Many studies compared the pre-
dictivity of SS and cSS, yet due to inconsistent results, the superiority of SS or cSS
still remains as an issue. In this study, we investigated the predictivity of SS and cSS
in various clinical situations.
Methods: Patients were enrolled from the Efﬁcacy of Xience/Promus versus Cypher
in rEducing Late Loss after stENTing (EXCELLENT) registry. SS and cSS were
checked at an independent angiographic core lab. The primary clinical outcome was 3-
year patient-oriented composite endpoint (POCE; a composite of all cause death, any
myocardial infarction, and any revascularization).
Results:We calculated SS and cSS for the 5,102 patients from the EXCELLENT
registry. When patients had a risk factor such as old age, hypertension, diabetes,
current smoking, low ejection fraction, renal insufﬁciency and no use of statin,
the cSS was superior to SS, whereas in patients without risk factors, there was no
additive value of the cSS. Patients were divided into 3 groups, according to the
number of risk factors present. As a result, 37.1% were in the low risk group
(0-2 risk factors), 30.8% were in the intermediate risk group (3 risk factors) and
27.1% were in the high risk group (4-7 risk factors). POCE increased according
to risk group; 10.4%, 13.4%, 18.9%, p< 0.001 in the low, intermediate, high risk
group respectively. Also by receiver operating characteristic analysis, predictivity
of SS was superior to cSS in the low risk group whereas in the intermediate
and high risk group, cSS was superior (low risk group: 0.631 vs. 0.637, inter-
mediate risk group: 0.598 vs. 0.632, high risk group: 0.600 vs. 0.644, for SS
and cSS).
Conclusions: SS is superior to cSS in low risk patients, whereas in high risk patients,
the cSS has better predictivity. The presence of classical risk factors should be
considered when using the SS as a predictive tool after revascularization.
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Background: Incomplete revascularization (IR) is associated with adverse short and
long-term clinical outcomes after percutaneous coronary intervention (PCI). Recently
the residual SYNTAX Score was reported as an objective measure of the degree and
complexity of residual stenosis after PCI. Limited information exists regarding IR in
patients with previous CABG undergoing PCI, and formal quantiﬁcation of residual
atherosclerosis after PCI in those patients has not been performed. Our objective was
to quantify the extent and complexity of residual coronary stenoses following PCI in
patients with previous CABG and to evaluate its impact upon mortality.
Methods: Between 1/2012 and 1/2014, 94 patients with previous CABG underwent
PCI in our center. The baseline CABG SYNTAX score (basal CSS) and the CABG
SYNTAX score after PCI (residual CSS) were assessed. Patients with residual CSS
>0 were deﬁned as having IR and were stratiﬁed by residual CSS tertiles. The primary
endpoint was all-cause mortality at a median follow-up of 22.5 months (IQR range:
15.8-42.7 months).
Results: The basal CSS was 25.710.6, and after PCI the residual CSS was
16.910.3 (p< 0.01). Complete revascularization was achieved only in 3 patients
(3.2%). Among patients with IR (n¼91), by tertile grouping 29 patients (32%)
had residual CSS >0-12 (mean 7.63.2), 31 (34%) had residual CSS >12-20.5
(mean 15.72.5) and 31 patients (34%) had residual CSS >20.5 (mean
28.67.4). There were no differences in baseline characteristics and clinical
presentation between groups. Basal CSS (18.47.2, 23.36.1 and 36.57.7;
p< 0.01) and mean graft age (7.46.7, 9.15.5 and 12.58.3 years; p¼0.02)
were higher in those patients with high residual CSS. Thirty-day mortality was
higher in the high residual CSS group (3.4% vs. 6.5% vs. 25.8%, p¼0.02).
Kaplan-Meier analysis revealed that patients with high residual CSS score had
signiﬁcantly higher all-cause mortality rates (6.9% vs. 16.1% vs. 35.5%, log
rank¼0.014) during follow up.
Conclusions: The residual CSS is useful to quantify the degree and complexity of
residual coronary artery disease after PCI in patients with previous CABG and may
aid in determining a reasonable level of revascularization post PCI.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/AngiograpTCT-92
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Background: ST-segment resolution (STR) and myocardial blush grade (MBG) after
primary percutaneous coronary intervention (PCI) provide discordant measures of
reperfusion with independent prognostic signiﬁcance. Aim of the study was to eval-
uate with frequency domain OCT (FD-OCT) the amount of residual intrastent
thrombus, and relate it with STR and MBG.
Methods: One hundred twenty consecutive patients were studied and classiﬁed on the
basis of STR (  50% or > 50%) and MBG ( 0/1 or 2/3). Based on discordance or
concordance between STR and MBG after PCI, four groups were identiﬁed: group 1(6
patients): STR  50% and MBG 0/1; group 2 (5 patients): STR > 50% and MBG 0/1;
group 3 (87 patients): STR> 50% and MBG 2/3; group 4(22 patients): STR  50%
and MBG 2/3. Residual intrastent thrombus was calculated, with OCT, as stent area
minus lumen area; mean value of thrombus area (m-ThA,mmq) and % of thrombus
area (%ThA: thrombus area / stent area x 100) were also calculated. Killip class, and
left ventricular ejection fraction (LVEF) by echocardiography at discharge were
available in every patients. Clinical follow-up was completed for all at 1,3,6,12
months by phone interview.
Results: MBG 2/3 was achived in 91% (109/120) of the patients and STR > 50% in
77% of the patients (92/120). STR and MBG were discordant in 23% (27/120) and
concordant in 77% (93/120) of the patients. All but 6 patients underwent successful
OCT analysis. Overall mean value of m-ThA and %ThA were respectively 0.380.45
and 4.73.7. Group 2 and group 4 (with STR and MBG discordance) respectively
showed signiﬁcative difference regarding the m-ThA (0.60.3 vs 0.30.2; p¼0.008),
% ThA (7.03.3 vs 3.71.5; p¼ 0.004), LVEF at discharge (0.350.15 vs
0.51+0.8; p¼0.008), Killip class (2.2 vs 1.0; p¼0.002), and MACE (2/5 vs 0/22;
p¼0.03).
Conclusions: Residual intrastent thrombus after stenting for primary PCI can play a
role differentiating patients with discordance between STR and MBG. MBG 2/3
and STR  50% is associated with lower residual thrombus, better LVEF and
MACE than MBG 0/1 and STR>50%, so that MBG has more impact on prognosis
than STR.
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Background: Automatic 3D segmentation from rotational angiography is used for
guidance during atrial ﬁbrillation (AFIB) and transcatheter aortic valve replacement
(TAVR) procedures. The workﬂow can be improved by avoiding high oblique an-
gulations and hence the risk of a detector collision with the patient or equipment. We
investigate the impact of 3D reconstruction artifacts from reduced range C-arm to-
mography on the accuracy of the segmentation and its utility for guidance.
Methods: First, 57 consecutive rotational angiographies covering 200 angular range
of the left atrium (LA) and pulmonary veins (PV) acquired for AFIB treatment
guidance were reconstructed with varying ranges down to 110 by omitting pro-
jections. Second, 20 consecutive XperCT’s of the aortic root acquired with hyper-
pacing for TAVR guidance and an angular range of 180 (8) or 160 (12) were
reconstructed with ranges down to 110. In both setups, for each range a dedicated
segmentation model was trained, while expert annotations were available as ground
truth.
Results: For AFIB, the mean segmentation error for the LA+PV model only slightly
increases from 1.5mm for 200 to 2.0mm for 150 in matched training conditions (see
Fig.A). For TAVR, the median error for the valve plane angle compared to those from
full angular range stays below 2 down to about 140 (see Box-Whisker-Plot in
Fig.B).hy and QCA B27
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constructions provides accurate roadmaps down to 150 (AFIB) and 140 (TAVR)
and improves C-arm tomography workﬂow during cardiac interventions by avoiding
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Background: There has been a few data about the long-term clinical outcomes of
patients with coronary artery aneurysm (CAA) after drug-eluting stent (DES) im-
plantation. The aim of study is to explore the long-term clinical outcomes of CAA
after DES implantation.
Methods: A total of 94 patients with CAA (105 lesions) after DES implantation (CAA
group) were retrospectively compared with 523 patients (523 lesions) who underwent
DES implantation (non-CAA group). The primary end point was deﬁned as major
adverse cardiac events (MACE) : composites of all-cause death, non-fatal myocardial
infarction (MI), or target vessel revascularization (TVR). Propensity score-matching
analysis was performed in 85 patient pairs.
Results: CAA group had higher incidence of hypertension (64.9% vs. 53.2%,
p¼0.03), lower incidence of dyslipidemia (55.3% vs. 67.2%, p¼0.02), andB28 JACC Vol 64/11/Suppl B j Septemblonger duration of dual antiplatelet therapy (1323860day vs. 767636day,
p< 0.01). Procedural data showed that CAA group had more 1st generation DES
(95.2% vs. 51.4%, p< 0.01), lower stent size (3.000.33mm vs. 3.190.44mm,
p< 0.01) and longer stent length (38.218.5mm vs. 31.717.6mm, p< 0.01).
During a median follow-up period of 860802 days, CAA group had signiﬁ-
cantly higher incidence of MACE (34.0% vs. 7.7%, p< 0.01), which was mainly
driven by non-fatal MI (13.8% vs. 0.76%, p< 0.01) and TVR (28.7% vs. 1.53%,
p< 0.01). The incidence of stent thrombosis was also higher in CAA group
(10.64% vs. 0.19%, p< 0.01). Cox proportional hazard analysis demonstrated
that independent predictors for MACE were CAA (hazard ratio [HR]: 2.53,
[95% conﬁdence interval (CI): 1.528-4.186]), stent number (HR: 1.62, 95% CI:
1.002-2.626), and the prior coronary artery bypass (HR: 4.84, 95% CI: 1.464-
16.029). After propensity-score matching, CAA group still had signiﬁcantly
higher incidence of MACE (32.9% vs. 5.8%, p< 0.01), non-fatal MI (14.1% vs.
0%, p< 0.01), TVR (27% vs. 1.2%, p< 0.01), and stent thrombosis (10.6% vs.
0%, p< 0.01).
Conclusions: CAA group had worse long-term clinical outcomes than non-CAA
group, especially by increase of stent thrombosis, non-fatal MI or TVR. Indeﬁnite use
of DAPT may be needed for CAA patients.
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Background: Elevations of cardiac troponin (cTn) over the upper reference limit
(URL) is a well known predictor of adverse prognosis in unstable coronary artery
disease (CAD). Novel more sensitive cTn assays have the potential for stratifying cTn
levels within the normal range also in patients with apparently stable CAD. The aim of
our study was to evaluate the prognostic value of preprocedural cTnI levels below the
URL, measured with a contemporary available sensitive assay, in stable CAD patients
treated with percutaneous coronary interventions (PCI).
Methods: In 1063 consecutive patients with normal baseline cTnI levels treated with
elective and angiographically successful PCI, we investigated the correlation between
pre-PCI cTnI levels and major clinical adverse events (median follow up of 3.0 years).
Results: Preprocedural cTnI levels were stratiﬁed into tertiles. When compared with
the lower, the upper tertile showed an increased long term risk of overall death (HR
3.17, 95% CI 1.62 to 6.21; P¼0.0001), cardiac death (HR 5.09, 95% CI 2.30 to 11.25;
P¼0.002), myocardial infarction (MI) (HR 2.34, 95% CI 1.45 to 3.76; P¼0.003) and
target vessel failure (TVF) (HR 1.91, 95% CI 1.28 to 2.84; P¼0.006). After adjust-
ment for clinical and angiographic ﬁndings, baseline cTnI level remained an inde-
pendent predictor of cardiac death, MI and TVF.
Conclusions: In a large single-centre population of stable CAD patients treated with
successful PCI, pre-procedural cTnI level, even if below the URL, resulted a strong
independent predictor of long term hard end points.
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Background: Beta-blocker therapy has been shown to beneﬁt in patients presenting
with acute coronary syndrome or left ventricular (LV) dysfunction. However, whether
beta-blockers provide a similar beneﬁt in stable coronary artery disease (SCAD) pa-
tients with normal LV function after percutaneous coronary intervention (PCI) is
unknown.
Methods: A population of 4,266 patients with SCAD with normal LV function who
were treated by PCI was evaluated. Among those, beta-blocker was prescribed in 2794
(65.5%) patients. Primary endpoint was the composite of death from any cause and
spontaneous myocardial infarction (MI).
Results: During the mean follow-up of 31.510.4 months, primary endpoint of
the composite of death and MI were occurred in 97 (3.5%) patients with beta-
blocker and 62 (4.2%) patients without beta-blocker, respectively. Unadjusted
hazard ratio (HR) for the primary end-points was 0.819 (95% CI 0.595 to 1.126,
p¼0.219); for death, 0.724 (95% CI, 0.510 to 1.028, p¼0.071); for MI, 1.136
(95% CI, 0.573 to 2.251, p¼0.700). After adjusting baseline characteristics,
adjusted HR was 0.802 (95% CI 0.577 to 1.116, p¼0.191) for the primary-
endpoint; 0.729 (95% CI 0.507 to 1.047, p¼0.087) for death; 1.124 (95% CI
0.562 to 2.248, p¼0.741) for MI.
Conclusions: In SCAD patients with normal LV function after PCI, beta-blocker was
not associated with signiﬁcant reduction of death or MI.er 13–17, 2014 j TCT Abstracts/Angioplasty Overview and Outcomes
